PP
THRD

PDT Partners’s Third Harmonic Bio THRD Stock Holding History

PDT Partners’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-30,118
Closed -$164K – 726
2025
Q2 		$164K Buy
+30,118
New +$150K 0.01% 649
2025
Q1 		– Sell
-18,642
Closed -$192K – 853
2024
Q4 		$192K Sell
18,642
-4,661
-20% -$58.1K 0.02% 661
2024
Q3 		$316K Buy
23,303
+3,800
+19% +$47.1K 0.03% 594
2024
Q2 		$254K Hold
19,503
– – 0.02% 580
2024
Q1 		$184K Buy
19,503
+9,221
+90% +$89.6K 0.02% 582
2023
Q4 		$113K Buy
+10,282
New +$81.5K 0.01% 517

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AB
Amalgamated Bank New York $13.1B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

PDT Partners's THRD Position: Q3 2025 in Review

PDT Partners sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 30,118 shares — an estimated $164K sold.

PDT Partners first reported a position in THRD in Q4 2023 and held it in 6 quarters. The position peaked at $316K in Q3 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • PDT Partners reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • PDT Partners sold 30,118 Third Harmonic Bio shares in Q3 2025, an estimated $164K.
  • PDT Partners first reported a position in Third Harmonic Bio in Q4 2023 and held it in 6 quarters.
  • PDT Partners's Third Harmonic Bio position peaked at $316K in Q3 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on PDT Partners's 13F filing for Q3 2025, filed 17 Nov 2025.